Patents Assigned to The Regents of the University
-
Patent number: 9688533Abstract: A new packaging method for a wide range of MEMS for application on both the wafer and device scale. Titanium is used as the packaging material and both silicon and titanium MEMS devices are integrated on to a titanium substrate. A Nd:YAG pulsed laser is used to micro-weld the titanium cap to the substrate. A three-dimensional time dependent model of heat flow during laser beam welding is presented. The heat transfer and parametric design capabilities of COMSOL were employed for this purpose. Model calculations are compared and calibrated with experimental results of pulsed laser welds. The functionality and hermiticity of the proposed packaging was evaluated by packaging a self actuated Veeco Instrument AFM cantilever tip. The experimental measurements show that the resonance frequency and quality factor of the device stay the same before and after packaging and the applied technique has no effect on the device.Type: GrantFiled: January 31, 2012Date of Patent: June 27, 2017Assignee: The Regents of the University of CaliforniaInventors: Payam Bozorgi, Noel C. MacDonald
-
Patent number: 9687840Abstract: The invention includes compositions comprising curable imidazolium-functionalized poly(room-temperature ionic liquid) copolymers and homopolymers. The invention further includes methods of preparing and using the compositions of the invention. The invention further includes novel methods of preparing thin, supported, room-temperature ionic liquid-containing polymeric films on a porous support. In certain embodiments, the methods of the invention avoid the use of a gutter layer, which greatly reduces the overall gas permeance and selectivity of the composite membrane. In other embodiments, the films of the invention have increased gas selectivity and permeance over films prepared using methods described in the prior art.Type: GrantFiled: July 9, 2013Date of Patent: June 27, 2017Assignee: The Regents of the University of Colorado, a body corporateInventors: Douglas Gin, Trevor Carlisle, Richard Noble, Garret Nicodemus, William McDanel, Matthew Cowan
-
Publication number: 20170176272Abstract: The development of a stress-responsive colorimetric film that can memorize the stress it has experienced is disclosed. The system can use the plasmonic shift associated with the disassembly of one-dimensional plasmonic nanoparticle chains driven by the plastic deformation of the surrounding polymer matrix. By modifying the plasticity of the polymer, the plasmonic shift and colorimetric change can respond to a large range of stresses. The pressure indicating film can be used to capture and record the pressure distribution and magnitude between two contacting or impacting surfaces by outputting color information.Type: ApplicationFiled: April 6, 2015Publication date: June 22, 2017Applicant: The Regents of The University of CaliforniaInventors: Yadong YIN, Xiaogang HAN, Yiding LIU
-
Publication number: 20170174723Abstract: The present invention provides bi-terminal PEGylated peptide conjugates that target an integrin such as ?v?6 integrin. In particular embodiments, the peptide conjugates of the present invention further comprise a biological agent such as an imaging agent or a therapeutic agent, e.g., covalently attached to one of the PEG moieties. The peptide conjugates of the present invention are particularly useful for imaging a tumor, organ, or tissue and for treating integrin-mediated diseases and disorders such as cancer, inflammatory diseases, autoimmune diseases, chronic fibrosis, chronic obstructive pulmonary disease (COPD), lung emphysema, and chronic wounding skin disease. Compositions and kits containing the peptide conjugates of the present invention find utility in a wide range of applications including, e.g., in vivo imaging and immunotherapy.Type: ApplicationFiled: October 13, 2016Publication date: June 22, 2017Applicant: The Regents of the University of CaliforniaInventors: Sven H. Hausner, Julie L. Sutcliffe
-
Publication number: 20170173174Abstract: The present invention is directed to bladder cancer specific ligand peptides, comprising the amino acid sequence X1DGRX5GF (SEQ ID NO: 1), and methods of their use, e.g., for imaging detection for diagnosis of bladder, tumor localization to guide transurethral resection of bladder cancer, imaging detection of bladder cancer for follow-up after the initial treatment that can replace or complement costly cystoscopy, imaging detection of metastatic bladder cancer, and targeted therapy for superficial and metastatic bladder cancer.Type: ApplicationFiled: January 7, 2017Publication date: June 22, 2017Applicant: The Regents of the University of CaliforniaInventors: Chong-Xian PAN, Hongyong ZHANG, Kit S. LAM, Olulanu H. AINA
-
Publication number: 20170174722Abstract: The present invention provides compounds and pharmaceutical compositions of a peptidomimetic ligand, e.g. LLP2A, conjugated with a bisphosphonate drug, e.g. Alendronate. The compounds and pharmaceutical compositions of the present invention are useful in the treatment of osteoporosis and for the promotion of bone growth due to their specificity for the ?4?1 integrin on mesenchymal stem cells and for the surface of bone.Type: ApplicationFiled: December 21, 2016Publication date: June 22, 2017Applicant: The Regents of the University of CaliforniaInventors: Kit S. Lam, Ruiwu Liu, Wei Yao, Nancy Lane
-
Publication number: 20170175290Abstract: This disclosure provides systems, methods, and apparatus related to the growth of single crystal III-V semiconductors on amorphous substrates. In one aspect, a shape of a semiconductor structure to be formed on an amorphous substrate is defined in a resist disposed on the amorphous substrate. A boron group element is deposited over the amorphous substrate. A ceramic material is deposited on the boron group element. The resist is removed from the amorphous substrate. The ceramic material is deposited to cover the boron group element. The amorphous substrate and materials deposited thereon are heated in the presence of a gas including a nitrogen group element to grow a single crystal semiconductor structure comprising the boron group element and the nitrogen group element.Type: ApplicationFiled: November 17, 2016Publication date: June 22, 2017Applicant: The Regents of the University of CaliforniaInventors: Kevin Chen, Rehan Kapadia, Ali Javey
-
Publication number: 20170175202Abstract: The invention described in the application relates to a panel of gene expression markers for patient with a tumor. The invention thus provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to evaluate the likelihood of disease progression or response to chemotherapy or radiation therapy. Such information can be usd in determining prognosis and treatment options for cancer patients.Type: ApplicationFiled: May 18, 2015Publication date: June 22, 2017Applicant: The Regents of the University of CaliforniaInventors: Weiguo Zhang, Gary Karpen, Jian-Hua Mao
-
Publication number: 20170173041Abstract: Provided herein are compositions methods of using liposomally encapsulated therapeutic drugs, such as staurosporine. Further provided herein are methods of using the liposome compositions to treat a cancer.Type: ApplicationFiled: March 27, 2015Publication date: June 22, 2017Applicant: The Regents of The University of CaliforniaInventors: Santosh Kesari, Rajesh Mukthavaram, Milan T. Makale, Wolfgang J. Wrasidlo
-
Patent number: 9683996Abstract: The present disclosure is directed toward measurement of expression of one or both of an activating Natural Killer (NK) cell receptor and its ligand(s) on peripheral blood cells as a means to assess solid tumor burden. In particular, the present disclosure provides tools for assessing cancer recurrence or risk thereof following reduction of a solid tumor, and for developing a treatment regime for a cancer patient.Type: GrantFiled: October 22, 2010Date of Patent: June 20, 2017Assignee: The Regents of the University of CaliforniaInventors: Andrew T. Parsa, Lewis L. Lanier, Courtney Crane
-
Patent number: 9683025Abstract: The invention provides a peptide construct comprising a cell penetrating peptide and an inhibitory peptide that interferes with the interaction between E1A and CtBP. The invention also provides related pharmaceutical composition comprising such a peptide construct. Also provided is a conjugate comprising such a peptide construct and a carrier molecule. The invention also provides related pharmaceutical compositions. Also provided are related methods of inhibiting cell proliferation in an individual and methods of treating cancer in by such pharmaceutical compositions. The present application also provides methods of treating an inflammatory disease and inhibiting inflammation in an individual comprising administering to the individual an effective amount of a therapeutic agent comprising an inhibitory peptide that interferes with the interaction between E1A and CtBP.Type: GrantFiled: March 13, 2014Date of Patent: June 20, 2017Assignee: The Regents of the University of Colorado, a body corporateInventors: Qinghong Zhang, Rui Zhao, Xiao-Jing Wang, Melanie Blevins
-
Patent number: 9681946Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: GrantFiled: February 26, 2016Date of Patent: June 20, 2017Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
-
Patent number: 9682151Abstract: Disclosed herein, in certain embodiments, is a selective transport molecule with increased in vivo circulation. In some embodiments, a selective transport molecule disclosed herein has the formula (A-X-B-C)-M, wherein C is a cargo moiety; A is a peptide with a sequence comprising 5 to 9 consecutive acidic amino acids, wherein the amino acids are selected from: aspartates and glutamates; B is a peptide with a sequence comprising 5 to 20 consecutive basic amino acids; X is a linker; and M is a macromolecular carrier.Type: GrantFiled: July 15, 2010Date of Patent: June 20, 2017Assignee: The Regents of the University of CaliforniaInventors: Roger Tsien, Todd Aguilera, Emilia Olson, Tao Jiang, Quyen Nguyen
-
Patent number: 9683285Abstract: This disclosure provides systems, methods, and apparatus related to blocking macroparticles in deposition processes utilizing plasmas. In one aspect, an apparatus includes a cathode, a substrate holder, a first magnet, a second magnet, and a structure. The cathode is configured to generate a plasma. The substrate holder is configured to hold a substrate. The first magnet is disposed proximate a first side of the cathode. The second magnet is disposed proximate a second side of the substrate holder. A magnetic field exists between the first magnet and the second magnet and a flow of the plasma substantially follows the magnetic field. The structure is disposed between the second side of the cathode and the first side of the substrate holder and is positioned proximate a region where the magnetic field between the first magnet and the second magnet is weak.Type: GrantFiled: March 18, 2014Date of Patent: June 20, 2017Assignee: The Regents of the University of CaliforniaInventors: Andre Anders, Jonathan Kolbeck
-
Patent number: 9685676Abstract: Bioelectrochemical systems (BES) having configurations with spiral wound structures and with frame-and-plate structures are provided. Systems may allow for production of an electrical current that is at least partially generated by microorganisms connected directly or indirectly to an electrode. A spiral wound or frame-and-plate type bioelectrochemical system that may be used for energy or chemical production, and/or desalination may include an anolyte influent point, a catholyte influent point, electrodes, ion selective membranes, mesh separators, gas collection devices, an exterior containment vessel, and one or more external electrical devices.Type: GrantFiled: September 14, 2012Date of Patent: June 20, 2017Assignee: The Regents of the University of ColoradoInventors: Zhiyong Ren, Casey Forrestal, Pei Xu
-
Publication number: 20170170909Abstract: A system that performs heterodyne optical imaging across multiple platforms gathers an optical signal from an optical sensor at each of the multiple platforms. At the same time, an optical frequency comb local oscillator (LO) at each of the platforms generates a reference comb signal comprising a set of optical frequency comb lines at different frequencies, wherein each optical frequency comb LO is locked to a local atomic clock at each of the platforms. Next, a mixer, at each of the platforms, is used to mix the optical signal gathered from the optical sensor with the reference comb signal generated by the optical frequency comb LO to generate a mixed signal. The system then communicates the mixed signals generated at each of the platforms to a central location. Finally, the system correlates the mixed signals received from each of the platforms and generates a reconstructed optical image.Type: ApplicationFiled: December 13, 2016Publication date: June 15, 2017Applicant: The Regents of the University of CaliforniaInventor: Sung-Joo Ben Yoo
-
Publication number: 20170164825Abstract: A three-dimensional (three dimensional) segmentation method with intensity-based Doppler variance (IBDV) based on swept-source OCT. The automatic three dimensional segmentation method is used to obtain seven surfaces of intra-retinal layers. The microvascular network of the retina, which is acquired by the IBDV method, can be divided into six layers. The microvascular network of the six individual layers are visualized, and the morphology and contrast images can be improved by using the segmentation method. This method has potential for earlier diagnosis and precise monitoring in retinal vascular diseases. Each tomographic image is composed of eight repeat scans at the same position, which achieves a high time difference to improve the sensitivity of the angiographic method. A subpixel registration algorithm is used to reduce the eye movement. The GPU was used to accelerate the data processing to achieve real-time preview of the acquired data.Type: ApplicationFiled: June 21, 2016Publication date: June 15, 2017Applicant: The Regents of the University of CaliforniaInventors: Zhongping Chen, Lu Fan, Shenghai Huang
-
Publication number: 20170166861Abstract: A method of culturing pluripotent stem cells is provided. The method includes culturing pluripotent stem cells in a pluripotent stem cell culture medium supplemented with an additive, where the additive includes a source of acetate ions, a carboxylic acid, or a physiologically acceptable salt of the carboxylic acid, or a combination of these substances, in an amount effective to maintain the pluripotent stem cells in culture in an undifferentiated pluripotent state. Also included are pluripotent stem cell culture media and methods of making such media.Type: ApplicationFiled: December 15, 2016Publication date: June 15, 2017Applicant: The Regents of the University of CaliforniaInventors: Prudence Talbot, Sabrina Lin, Antonio Loza
-
Patent number: 9681389Abstract: An integrated ultra wideband transceiver. The transceiver comprises a transmitter, a receiver, and at least one on-chip monopole antenna electrically connected to at least one of the transmitter or receiver for transmitting and/or receiving electrical signals. The transceiver further comprises a clock generator comprising a temperature-compensated relaxation oscillator, a baseband controller electrically connected to, and configured to exert a measure of control over, at least one the transmitter, receiver, or clock generator, and a micro-battery operative to provide operating power to each of the transmitter, receiver, clock generator, and baseband controller.Type: GrantFiled: February 17, 2014Date of Patent: June 13, 2017Assignee: The Regents of the University of MichiganInventors: David D. Wentzloff, Jonathan K. Brown, Kuo-Ken Huang, Elnaz Ansari, Ryan R. Rogel
-
Patent number: 9675923Abstract: Fe2(dobdc) has a metal-organic framework with a high density of coordinatively-unsaturated FeII centers lining the pore surface. It can be effectively used to separate O2 from N2 and in a number of additional separation applications based on selective, reversible electron transfer reactions. In addition to being an effective O2 separation material, it can be used for many other processes, including paraffin/olefin separation, nitric oxide/nitrous oxide separation, acetylene storage, and as an oxidation catalyst.Type: GrantFiled: August 24, 2012Date of Patent: June 13, 2017Assignee: The Regents of the University of CaliforniaInventors: Jeffrey R. Long, Eric D. Bloch, Leslie Murray